A recent PlasticsToday article based on IDTechEx analysis highlights a major shift in the bioplastics industry. Polyhydroxyalkanoates and polyethylene furanoate are expected to become two disruptive material families over the next decade. Their combined global production capacity is forecast to move toward two million tonnes per year by 2036, representing 13% of global bioplastics production. For industrial buyers, the message is clear: material sourcing strategies should now look beyond PLA and partially bio-based PET.
Why PHAs Are Moving from Niche Material to Strategic Option
A Biopolymer Produced by Microorganisms
PHAs, or polyhydroxyalkanoates, are naturally occurring biopolymers produced inside living microorganisms. According to the article, microbes can convert renewable feedstocks such as sugars, fatty acids and methane biogas into PHAs. These polymers act as an energy storage material inside the cells and can represent up to 80% of total cell volume.
This production route gives PHAs a distinct position within the wider bioplastics market. Unlike some synthetic bio-based polymers, they are generated through a biological process and can then be isolated from bioreactors using solvent extraction or enzymatic degradation methods. The source also notes that this process creates limitations, since batch-to-batch production can be inconsistent and expensive.
For B2B buyers, this combination of promise and complexity is important. PHA bioplastics are not simply a drop-in commodity material. They require careful assessment of grade, application, supplier reliability, certification and production scale. Companies beginning this evaluation can explore more information on PHA biopolymers and their industrial relevance.
Cost Reduction Will Be Critical for Wider Adoption
The article reports that PHA prices currently remain high, at approximately $4 to $6 per kilogram. However, it also states that costs are falling as production scales up and as fermentation and recovery steps are optimized. IDTechEx identifies cost parity with PLA, estimated at $2 to $3 per kilogram, as crucial for the success of PHAs.
This cost comparison matters because both material families are positioned for biodegradable single-use applications. The article specifically mentions packaging, cups and cutlery as target markets. For procurement teams, the commercial question is therefore not only whether PHAs offer environmental advantages, but whether these advantages justify the current premium in specific product categories.
That premium may be easier to evaluate in applications where sustainability performance, consumer perception or regulatory pressure carry strategic value. Examples include biodegradable packaging, single-use cups and PHA food ware. In these segments, buyers are often looking for alternatives that can reduce dependence on conventional plastics while maintaining usability at commercial scale.
How PHAs and PEF Could Change Bioplastics Procurement
Different Materials, Different Market Roles
The source presents PEF as a synthetic bioplastic produced through the polymerization of monoethylene glycol with 2,5-furandicarboxylic acid. Bio-based monoethylene glycol derived from bioethanol is already available, while bio-based FDCA production remains at pilot stage. The article explains that FDCA can be obtained from fructose through fermentation and metal-catalyzed oxidation steps.
PEF is positioned as a more sustainable alternative to PET because both of its constituent monomers can be bio-based. Its market opportunity is also linked to performance. The reports that PEF offers enhanced mechanical, thermal and gas barrier properties, which could support the replacement of PET in food packaging and textile fibers.
This distinction is useful for industrial buyers comparing bioplastic types. PEF is mainly discussed as a PET challenger for packaging and fibers, while PHAs are highlighted for enhanced biodegradability, biocompatibility and tunability. The materials should therefore be assessed by application, not treated as interchangeable solutions.
Biodegradability, Biocompatibility and Tunability Strengthen the PHA Case
Enhanced biodegradability is one of the central advantages attributed to PHAs. The source states that PHAs spontaneously decompose in marine environments, while PLA requires industrial composting. It also highlights biocompatibility, linked to microbial origin, as a factor enabling applications in biomedical equipment.
Another technical advantage is tunability. The article explains that monomers of different lengths can be selectively incorporated using genetic engineering techniques. This makes it possible to vary the final structure and material properties of the polymer. For industrial product development, this point is significant because different applications may require different balances of flexibility, rigidity, durability or processability.
These characteristics support the growing interest in PHA bioplastics for both finished products and material development. Buyers and converters should still validate each product against technical specifications, applicable regulations and certification requirements. PHA Sourcing’s information on PHA certifications can help teams structure this evaluation before moving toward sourcing or product testing.
What This Means for Companies Planning Material Transitions
Production Capacity Forecasts Point to a More Diverse Market
According to the article, the bioplastics industry has been shaped for more than 20 years by materials such as PLA and partially bio-based PET. The forecast for PHAs and PEF suggests a broader market structure by 2036, with new materials capturing a meaningful share of global bioplastics production.
For industrial companies, this does not mean every application should immediately switch materials. It means procurement, R&D and sustainability teams should begin mapping where emerging bioplastics could create value. Packaging buyers may compare PEF’s barrier properties with PET requirements, while foodservice buyers may assess PHAs for disposable applications where biodegradability is a priority.
This application-led approach is especially relevant for companies working on packaging applications, disposable serviceware or custom product development. Instead of asking which bioplastic is best in general, buyers should define the performance target, cost range, regulatory context, end-of-life pathway and supply requirements for each product family.
From Market Forecast to Practical Sourcing Decisions
The article states that PEF commercialization is expected from 2026 onward as leading players increase FDCA production, establish partnerships and sign off-take agreements with brands. It also reports an expected compound annual growth rate of 88.7% for the PEF industry through 2036. These projections show strong momentum, but they also underline the importance of timing in material adoption.
For PHAs, the key commercial issue remains the balance between cost, production scale and the value of enhanced biodegradability. Companies preparing for future procurement should evaluate supplier capabilities, available grades, product formats and potential certification needs. Those developing their own products can also review PHA product development and PHA pellet sourcing as part of a structured transition plan.
The next decade of bioplastics growth will not be driven by one single material. It will be shaped by fit-for-purpose solutions. For companies exploring PHA bioplastics for packaging, cups, cutlery or industrial applications, contact PHA Sourcing to discuss sourcing options and product requirements.
